Amplicon details |
||
Amplicon: |
173 bp | |
1 ggatctcctg tcatctcacc ttgctcctgc cgagaaagta tccatcatgg 51 ctgatgcaat gcggcggctg catacgcttg atccggctac ctgcccattc 101 gaccaccaag cgaaacatcg catcgagcga gcacgtactc ggatggaagc 151 cggtcttgtc gatcaggatg atc |
||
| Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
|---|---|---|---|---|---|---|---|
| JN948493.1 | emblreltgn | Mus musculus targeted non-condition... | 39169 bp | Mus musculus | QL-ELE-00-003 | 173 bp | View |
| NRN_BD063790 | nrnl1 | Insulin-like growth factor I(IGF)-1... | 3599 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_DI050738 | nrnl1 | COMPOSITIONS AND METHODS FOR HIGH-L... | 12109 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_AX000480 | nrnl1 | Sequence 11 from Patent WO9905285. ... | 3481 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_AR705765 | nrnl1 | Sequence 1 from patent US 6930095. | 7992 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_AR649148 | nrnl1 | Sequence 4 from patent US 6875581. ... | 6268 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_BD195386 | nrnl1 | Composition and methods for adminis... | 5446 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_DD107527 | nrnl1 | Novel Recombinant Gene Expression M... | 5408 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_AR705770 | nrnl1 | Sequence 6 from patent US 6930095. | 7992 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_DI091702 | nrnl1 | COMPOSITIONS AND METHODS FOR HIGH-L... | 12704 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_DD082377 | nrnl1 | A method to increase ability of DNA... | 7478 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| JN948494.1 | emblreltgn | Mus musculus targeted non-condition... | 38168 bp | Mus musculus | QL-ELE-00-003 | 173 bp | View |
| NRN_BD063789 | nrnl1 | Insulin-like growth factor I(IGF)-1... | 3600 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_DD107525 | nrnl1 | Novel Recombinant Gene Expression M... | 7873 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_DJ474360 | nrnl1 | DNA EXPRESSION VECTORS AND METHODS ... | 9918 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CQ812178 | nrnl1 | Sequence 5 from Patent EP1418185. ... | 38306 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| JN948495.1 | emblreltgn | Mus musculus targeted non-condition... | 40324 bp | Mus musculus | QL-ELE-00-003 | 173 bp | View |
| NRN_DI118835 | nrnl1 | Persistent Expression of Candidate ... | 12607 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_DJ027895 | nrnl1 | Treatment and prevention of disease... | 6204 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CQ821461 | nrnl1 | Sequence 17 from Patent EP1428886. | 7235 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.